Skip to content
The Nexus
DossierENTITY

VivoSim Labs, Inc.

Coverage of VivoSim Labs, Inc. in the Nexus archive.

Earliest in view: Jul 14 · 21:15 UTCMost recent: Jul 14 · 21:15 UTC
Co-mentioned in this coverage
San Diegoplace1Automated Insightsorganization1Zacks Investment Researchorganization1functional human tissue for drug and biological researchtopic1
Recent coverage
  • BUSINESSJul 14 · 21:15 UTCWTOP DC
    VivoSim: Fiscal Q4 Earnings Snapshot

    VivoSim Labs, Inc. (VIVS) reported a $5.8 million loss in its fiscal fourth quarter, with $2.21 per share loss and $40,000 in revenue. The company posted a $13.8 million annual loss, or $5.35 per share, with $131,000 in yearly revenue. The San Diego-based firm focuses on commercializing functional human tissue for drug and biological research.

VivoSim Labs, Inc. · Dossier · The Nexus